Home/Filings/4/0001178913-16-004401
4//SEC Filing

PLURISTEM THERAPEUTICS INC 4

Accession 0001178913-16-004401

$PLURCIK 0001158780operating

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 4:09 PM ET

Size

5.9 KB

Accession

0001178913-16-004401

Insider Transaction Report

Form 4
Period: 2016-02-11
Aberman Zami
DirectorCEO & Co. Chairman
Transactions
  • Purchase

    Common Stock

    2016-02-11$0.80/sh+31,000$24,71691,400 total(indirect: By Rose Hitech Ltd.)
Holdings
  • Common Stock

    2,118,298
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.7798 to $0.8105, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range.

Issuer

PLURISTEM THERAPEUTICS INC

CIK 0001158780

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001158780

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:09 PM ET
Size
5.9 KB